Indeed, NRAS mutations in melanoma are associated with a reduced presence of tumor‐infiltrating immune cells, suggesting an immunosuppressive microenvironment, which might explain the poor response to immunotherapy (Thomas et al, 2015). Here, NRAS is linked to neoplasm.